Researchers have successfully developed a novel drug to restore vision. The treatment method restores vision through retinal nerve regeneration. Vision is one of the most crucial human senses, yet ...

Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...

The device could help a million people with a severe form of macular degeneration to be able to see enough to read. By Gina Kolata For the first time, researchers restored some vision to people with a ...

Vision is one of the most crucial human senses, yet more than 300 million people worldwide are at risk of vision loss due to various retinal diseases. While recent advancements in retinal disease ...

What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...

Gene therapy emerges as a transformative force in ophthalmology, offering renewed hope for patients with retinal diseases. This innovative approach targets both inherited and acquired conditions, ...

Roughly 200 million people worldwide live with age-related macular degeneration, a condition that erodes central vision and, ...

In life, few things are certain. But one is: It becomes harder to see well as you age. “There are three things we cannot avoid: death, taxes, and presbyopia, the gradual loss of the ability to read up ...

Overview of study design and analytical flow for identifying metabolic features associated with anti-VEGF therapy on macular edema (ME) patients (created with BioRender.com). anti-VEGF, anti-vascular ...

For the first time, researchers have restored some vision to people with a common type of eye disease by using a prosthetic retinal implant. If approved for broader use in the future, the treatment ...